DrugInformer Search

Erythromycin Related Joint stiffness

Official Government Database Reports5
Online Conversations2

Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients. To view the active ingredient report, please click here.

Tell us about your Experience with Erythromycin

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: Dizziness, Abdominal pain, Crying, Discomfort, Joint stiffness, Somnolence

Posted By Anonymous in askapatient.com on March 7, 2013 @ 12:00 am

Side Effects: tiredness ,abdominal pain ,stifness in neck .diarorea,visual trouble. dizzeness,loss appetite ,muscle stifness/back head stiffness/crying feeling unwell i stop that drug today and dont ...

Druginformer Identified Side Effects: Pain, Flushing, Urticaria, Joint stiffness, Oedema, Tenderness, Abasia

Posted By Anonymous in askapatient.com on April 17, 2010 @ 12:00 am

Side Effects: First day extreme pain in right hip, very stiff right leg made it difficult to walk, large red sore swollen skin on bottom of right foot. Subsequent days large skin hives torso even th...

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.